Results of a three-day outpatient trial of plasmocid and osarsol for malaria

Over the past three years, many observations on the use of plasmacide have already accumulated. Treatment of three-day malaria with plasmacid relieves febrile attacks in 93-94% of cases. The disappearance of plasmodium from peripheral blood occurs in 76-86%. In the course of treatment with plasmacid, relapses were recorded in 20-22%, occurring more often on the 2-3rd cycle of plasmacid application.